ResearcherUniversity of AucklandNo recent work listed
Jezrael L. Revalde
Matched on ORCID iD 0000-0002-8794-6784; OpenAlex author ID A5037685518. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 2
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper
Papers 2
- Curcumin and its cyclohexanone analogue inhibited human Equilibrative nucleoside transporter 1 (ENT1) in pancreatic cancer cells. Co-author DOI 10.1016/j.ejphar.2017.03.055↗
- Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. First author DOI 10.1007/s00280-010-1515-6↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- James William Paxton · 2 shared papers, 2011–2017 · strength 0.11
- Paper Curcumin and its cyclohexanone analogue inhibited human Equilibrative nucleoside transporter 1 (ENT1) in pancreatic can… DOI 10.1016/j.ejphar.2017.03.055↗
- Paper Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. DOI 10.1007/s00280-010-1515-6↗
- Yan Li · 2 shared papers, 2011–2017 · strength 0.11
- Paper Curcumin and its cyclohexanone analogue inhibited human Equilibrative nucleoside transporter 1 (ENT1) in pancreatic can… DOI 10.1016/j.ejphar.2017.03.055↗
- Paper Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. DOI 10.1007/s00280-010-1515-6↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.